Cardiointerv 2023 Soon to Be Held

The Latin American Society of Interventional Cardiology is inviting our entire community to take part in Cardiointerv 2023, to be held November 11 thru December 1.

The event will be featuring a world class scientific program, prestigious international guests and challenging live cases. 

CardioInterv 2023 has the institutional support of SOLACI.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Save the Date! CardioInterv 2025 – 25th International Symposium on Interventional Cardiology is Coming

From November 26 to 28, 2025, the 25th International Symposium on Interventional Cardiology – CardioInterv 2025 will take place, a scientific excellence event that...

Invitation of the MIL Group to RISE at the ESC 2024 Congress

The Group of Latin American Interventional Women invites you to participate in the next RISE, a professional development conference for women in cardiology promoted...

Artificial Intelligence in Complex PCI Cases – 2nd International Symposium of Cardiology

The Latin American Society of Interventional Cardiology invites the whole community to take part in the 2nd International Symposium of Cardiology entitled “Artificial Intelligence...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...